A constant load exercise during 10 minutes will be performed in a group of Chronic Obstructive Pulmonary Disease patients, in a basal condition (spontaneous breathing); under noninvasive mask ventilation and with high flow nasal cannula. With the aim of reducing dyspnea, increasing exercise tolerance, and unload respiratory muscles, three exercises will be compared in terms of use of respiratory muscles and neural drive measured with paraesternal electromyography.
Exercise in chronic obstructive pulmonary disease is limited by dynamic hyperinflation and respiratory muscle overloadleading to severe dyspnea. During exercise, the increase in neural respiratory drive is notable to match ventilatory demand, correlated with breathlessness. Non-Invasive Ventilation may improve neural respiratory drive uncoupling and exercise tolerance. The aim of this study will be prove if Non-Invasive Ventilation and High flow nasal cannula during exercise reduces neural respiratory drive and improves dyspnea, measured with paraesternal electromyography
Study Type
OBSERVATIONAL
Enrollment
12
Patients will perform 10 minutes, constant load, exercise in a cycloergometer. To set the load, a baseline incremental effort test will be performed previously (VISIT 1). Then, in a separate day (VISIT 2), the subject will perform 10 minutes cycling at the 75% load of that determined as maximum in VISIT 1, at a constant rate of 30 to 35 pedal revolutions per minute, in spontaneous breathing, with low flow oxygen through conventional nasal cannula adjusted to achieve SpO2 between 92to 94%
VISIT 2 Non invasive mask ventilation: parameters will be titrated during a free cycling period at the end of the spontaneous breathing exercise. Then, in a separate day (VISIT 3), with the same constant load, cycling cadence and under NIV, the patient will perform 10 min of cycling.
Javier Sayas Catalan
Madrid, Spain
Changes in Neural ventilator (NVU) (%)
the peak value (on the baseline) of the maximum muscle activity ( Root mean square EMG value in mV), both diaphragmatic (EMGDimax) and parasternal (EMGparamax) in the máximum intentional ventilation and maximum inspiratory peak (MIP) will be taken. This value will be consider 100% and based on this mean EMG will be calculate for a normalized EMGdi (RMS) and paraesternal in each ventilatory situation (spontaneous ventilation or under NIV). At each effort point (in each minute of the exercise protocol), the relationship between the normalized EMG value (parasternal and Diaphragmatic) and the tidal volume (obtained by integral of flow signal by means of a pneumotachograph connected to the VM -in NIV- or oronasal hermetic mask -in Vesp). To facilitate the interpretation of the expired TV, the mask without leakage will be used with the intentional leak connected in the circuit, before the pneumotachograph.
Time frame: 24 hours, 48 hours, 72 hours
Borg Scale Dyspnea evolution (points)
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
Time frame: Basal value at day 1 and every 60 seconds during the exercise
Borg Scale Dyspnea evolution (points)
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
Time frame: 24 hours later than day 1 (day 2) during the exercise every 60 seconds
Borg Scale Dyspnea evolution (points)
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
With constant flows of 50 lpm and with FiO2 adjusted according to SPO2, to obtain a constant saturation between 92 and 94%. The same pedaling load and frequency will be maintained, with similar variables collected.
Time frame: 48 hours later than day 1 (day 3) during the exercise every 60 seconds
Borg Scale Dyspnea evolution (points)
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
Time frame: 72 hours later than day 1 (day 4) during the exercise every 60 seconds
Transcutaneous pCO2 Final - inicial (mmHg)
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: Basal value at day 1 during the exercise
Transcutaneous pCO2 Final - inicial (mmHg)
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: During the exercise at day 2 ( 24 hours later than day 1)
Transcutaneous pCO2 Final - inicial (mmHg)
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: During the exercise at day 3 (48 hours later than day 1)
Transcutaneous pCO2 Final - inicial (mmHg)
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: During the exercise at day 4 (72 hours later than day 1 )
Total Training time (pedaling, minutes)
Total Time that the patient remains pedaling
Time frame: During the exercise at day 2 ( 24 hours later than day 1)
Total Training time (pedaling, minutes)
Total Time that the patient remains pedaling
Time frame: During the exercise at day 3 ( 48 hours later than day 1)
Total Training time (pedaling, minutes)
Total Time that the patient remains pedaling
Time frame: During the exercise at day 4 ( 72 hours later than day 1)
Stops (n)
Number of stops that the patient performs during the test
Time frame: During the exercise at day 2 ( 24 hours later than day 1)
Stops (n)
Number of stops that the patient performs during the test
Time frame: During the exercise at day 3 ( 48 hours later than day 1)
Stops (n)
Number of stops that the patient performs during the test
Time frame: During the exercise at day 4 ( 72 hours later than day 1)
Ineffective efforts %
Porcentage of ineffective efforts during the exercise
Time frame: During the exercise at day 2 ( 24 hours later than day 1)
Ineffective efforts %
Porcentage of ineffective efforts during the exercise
Time frame: During the exercise at day 3 ( 48 hours later than day 1)
Ineffective efforts %
Porcentage of ineffective efforts during the exercise
Time frame: During the exercise at day 4 ( 72 hours later than day 1)